Society for Neuroscience

Based in DC

🤖

AI Overview

With $1.7M in lobbying spend across 32 quarterly filings, Society for Neuroscience is a significant lobbying presence. Their lobbying covers 8 issue areas. Active from 2018 to 2025.

$1.7M

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2018	$335K
2019	$358K
2020	$270K
2021	$120K
2022	$138K
2023	$158K
2024	$160K
2025	$200K

Issues Lobbied

Education Budget/Appropriations Animals MED Immigration Labor Issues Science/Technology Small Business

Lobbying Firms

Society for Neuroscience

Lobbyists

Allen Segal Kathryn Grady Michael Heintz Adam Katz

Government Agencies Targeted

These are the government entities that Society for Neuroscience disclosed contacting in their lobbying filings.

Food & Drug Administration (FDA)HOUSE OF REPRESENTATIVESNatl Institutes of Health (NIH)Office of Management & Budget (OMB)SENATEState, Dept of (DOS)Transportation, Dept of (DOT)Health & Human Services, Dept of (HHS)Defense, Dept of (DOD)Energy, Dept ofNatl Science Foundation (NSF)Office of Science & Technology Policy (OSTP)White House OfficeHomeland Security, Dept of (DHS)Veterans Affairs, Dept of (VA)

View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Education, Budget/Appropriations, Animals, MED, Immigration and 3 more

Communication and outreach concerning the financial impacts of capping facilities and administrative costs to universities and research institutions.

Advocacy efforts related to FY18 and FY19 funding for National Institutes of Health (NIH) and the National Science Foundation (NSF). Additional advocacy efforts to support completion of FY18 appropria

Communication and outreach concerning the responsible use of animal models in biomedical research. Communication to the Food and Drug Administration (FDA) concerning the closure of the FDA's National

Outreach and communication on the over 1,000 neurological and neurodegenerative diseases that affect nearly 100 million Americans. Communication with NIH over the revised definition of "clinical rese

Communication within a larger coalition context, to express concern and impact to changes to the Application for Immigrant Visa and Alien Registration.